Back
Aligos Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
ALGS
Sponsored
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Sell
29
ALGS
Aligos Therapeutics
Last Price:
7.32
Seasonality Move:
-9.98%
7 Day Trial
ALL ACCESS PASS
$
7
Don't put a penny in AI stocks until you read this
Discover this under-the-radar AI stock now, ahead of the crowd.Aligos Therapeutics Price Quote
$7.32
-0.02 (-0.27%)
(Updated: October 23, 2024 at 11:25 AM ET)
Aligos Therapeutics Key Stats
Sell
29
Aligos Therapeutics (ALGS)
is a Sell
Day range:
$7.10 - $7.55
52-week range:
$6.76 - $30.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.97
P/B ratio:
0.35%
Volume:
44.6K
Avg. volume:
85.5K
1-year change:
-61.37%
Market cap:
$23.5M
Revenue:
$15.5M
EPS:
$-24.29
How Much Does Aligos Therapeutics Make?
-
How Much Are Aligos Therapeutics's Sales Annually?
ALGS Revenues are $15.5M -
How Much Profit Does Aligos Therapeutics's Make A Year?
ALGS net income is -$87.7M
Is Aligos Therapeutics Growing As A Company?
-
What Is Aligos Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.85% -
What Is Aligos Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Aligos Therapeutics Stock Price Performance
-
Did Aligos Therapeutics Stock Go Up Last Month?
Aligos Therapeutics share price went down by -19.69% last month -
Did ALGS's Share Price Rise Over The Last Year?
ALGS share price fell by -61.37% over the past 1 year
What Is Aligos Therapeutics 52-Week High & Low?
-
What Is Aligos Therapeutics’s 52-Week High Share Price?
Aligos Therapeutics has traded as high as $30.00 over the past 52 weeks -
What Is Aligos Therapeutics’s 52-Week Low Share Price?
Aligos Therapeutics has traded as low as $6.76 over the past 52 weeks
Aligos Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Aligos Therapeutics?
-
How Much Debt Does Aligos Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Aligos Therapeutics Have?
Cash and short term investments quarterly total is $94.5M -
What Is Aligos Therapeutics’s Book Value Per Share?
Book value per share is 21.07
Is Aligos Therapeutics Cash Flow Positive?
-
What Is ALGS Cash Flow From Operations?
Cash flow from operations (TTM) is -$85.2M -
What Is Aligos Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $88.2M -
What Is Aligos Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$48.7M
Aligos Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
ALGS return on invested capital is -110.22% -
What Is Aligos Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -65.26% -
What Is ALGS Return On Equity?
ROE is a measure of profitability and is -110.22%
Aligos Therapeutics Earnings Date & Stock Price
-
What Is Aligos Therapeutics's Stock Price Today?
A single share of ALGS can be purchased today for 7.34 -
What Is Aligos Therapeutics’s Stock Symbol?
Aligos Therapeutics trades on the nasdaq under the ticker symbol: ALGS -
When Is Aligos Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Aligos Therapeutics is scheduled on November 1, 2024 -
When Is ALGS's next ex-dividend date?
Aligos Therapeutics's next ex-dividend date is October 23, 2024 -
How To Buy Aligos Therapeutics Stock?
You can buy Aligos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Aligos Therapeutics Competitors
-
Who Are Aligos Therapeutics's Competitors?
Below is a list of companies who compete with Aligos Therapeutics or are related in some way:
Aligos Therapeutics Dividend Yield
-
What Is ALGS Dividend Yield?
Aligos Therapeutics’s dividend yield currently is 0% -
What Is Aligos Therapeutics’s Payout Ratio?
Aligos Therapeutics’s payout ratio is 0% -
When Did Aligos Therapeutics Last Pay A Dividend?
The latest dividend pay date is October 23, 2024 -
What Is Aligos Therapeutics’s Dividend Per Share?
Aligos Therapeutics pays a dividend of $0.00 per share
Aligos Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 118.75% |
Revenue: | -84.59% | 0% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 103.33 |
Upside from Last Price: | 1307.81% |